John Paulson insider trades: Bausch Health Companies (BHC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC






and 5 more companies
Open-market buys and sales
47 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 14, 2025 | BHC | ↑ Buy | 34,721,118 | $9.00 | $312.5M | By Managed Funds | Aug 14, 2025 (0d) |
| Aug 13, 2025 | BHC | ↑ Buy | 3,243,049 | $6.56 | $21.3M | By Managed Funds | Aug 13, 2025 (0d) |
| Jun 13, 2025 | BHC | ↑ Buy | 3,564,059 | $5.94 | $21.2M | By Managed Funds | Jun 17, 2025 (4d) |
| Jun 12, 2025 | BHC | ↑ Buy | 2,788,608 | $5.27 | $14.7M | By Managed Funds | Jun 12, 2025 (0d) |
| Jun 24, 2020 | BSIG | ↓ Sell | 647,263 | $9.79 | $6.3M | By Paulson & Co. Inc. | Jun 26, 2020 (2d) |
| Jun 24, 2020 | BSIG | ↑ Buy | 647,263 | $9.79 | $6.3M | By Paulson & Co. Inc. | Jun 26, 2020 (2d) |
| May 14, 2020 | BHC | ↑ Buy | 5,000,000 | $16.65 | $83.3M | By Managed Funds | May 14, 2020 (0d) |
| Feb 25, 2019 | BSIG | ↑ Buy | 14,790,038 | $13.95 | $206.3M | By Paulson & Co. Inc. | Feb 27, 2019 (2d) |
| Mar 6, 2018 | VRX | ↑ Buy | 7,066,629 | $15.40 | $108.8M | By Managed Funds | Mar 8, 2018 (2d) |
| Mar 6, 2018 | VRX | ↓ Sell | 7,066,629 | $15.40 | $108.8M | By Managed Funds | Mar 8, 2018 (2d) |
| Nov 16, 2017 | VRX | ↑ Buy | 344,216 | $14.40 | $5.0M | By Managed Funds | Nov 20, 2017 (4d) |
| Nov 16, 2017 | VRX | ↓ Sell | 344,216 | $14.39 | $5.0M | By Managed Funds | Nov 20, 2017 (4d) |
| Jun 7, 2012 | DLPH | ↓ Sell | 3,774,157 | $28.50 | $107.6M | Direct | Jun 11, 2012 (4d) |
| Jun 7, 2012 | DLPH | ↓ Sell | 225,843 | $28.50 | $6.4M | See | Jun 11, 2012 (4d) |
| May 4, 2012 | DLPH | ↓ Sell | 1,080,221 | $30.63 | $33.1M | Direct | May 4, 2012 (0d) |
| May 3, 2012 | DLPH | ↓ Sell | 11,901 | $30.68 | $365K | See | May 4, 2012 (1d) |
| May 1, 2012 | DLPH | ↓ Sell | 1,870,571 | $30.81 | $57.6M | Direct | May 1, 2012 (0d) |
| May 1, 2012 | DLPH | ↓ Sell | 22,729 | $30.81 | $700K | See | May 1, 2012 (0d) |
| Apr 26, 2012 | DLPH | ↓ Sell | 2,443,600 | $30.82 | $75.3M | Direct | Apr 26, 2012 (0d) |
| Apr 26, 2012 | DLPH | ↓ Sell | 9,400 | $30.78 | $289K | See | Apr 26, 2012 (0d) |
| Apr 19, 2012 | DLPH | ↓ Sell | 226,516 | $32.25 | $7.3M | Direct | Apr 23, 2012 (4d) |
| Apr 19, 2012 | DLPH | ↓ Sell | 73,484 | $32.25 | $2.4M | See | Apr 23, 2012 (4d) |
| Apr 18, 2012 | DLPH | ↓ Sell | 3,025,172 | $32.22 | $97.5M | Direct | Apr 18, 2012 (0d) |
| Apr 18, 2012 | DLPH | ↓ Sell | 6,828 | $32.38 | $221K | See | Apr 18, 2012 (0d) |
| Mar 29, 2012 | DLPH | ↓ Sell | 650,580 | $32.06 | $20.9M | Direct | Mar 30, 2012 (1d) |
| Mar 29, 2012 | DLPH | ↓ Sell | 49,420 | $32.08 | $1.6M | See | Mar 30, 2012 (1d) |
| Mar 19, 2012 | DLPH | ↓ Sell | 1,100,000 | $32.00 | $35.2M | Direct | Mar 21, 2012 (2d) |
| Mar 14, 2012 | DLPH | ↓ Sell | 3,295,000 | $32.00 | $105.4M | Direct | Mar 14, 2012 (0d) |
| Mar 5, 2012 | DLPH | ↓ Sell | 1,105,000 | $31.96 | $35.3M | Direct | Mar 7, 2012 (2d) |
| Dec 22, 2011 | ACAS | ↓ Sell | 1,966,695 | $7.15 | $14.1M | Direct | Dec 27, 2011 (5d) |
| Dec 22, 2011 | ACAS | ↓ Sell | 186,505 | $7.15 | $1.3M | See | Dec 27, 2011 (5d) |
| Oct 11, 2011 | ACAS | ↓ Sell | 1,212,646 | $6.68 | $8.1M | Direct | Oct 12, 2011 (1d) |
| Oct 11, 2011 | ACAS | ↓ Sell | 67,254 | $6.67 | $449K | See | Oct 12, 2011 (1d) |
| Oct 5, 2011 | ACAS | ↓ Sell | 928,441 | $6.42 | $6.0M | Direct | Oct 7, 2011 (2d) |
| Oct 5, 2011 | ACAS | ↓ Sell | 256,618 | $6.43 | $1.7M | See | Oct 7, 2011 (2d) |
| Oct 4, 2011 | ACAS | ↓ Sell | 3,985,723 | $7.01 | $27.9M | Direct | Oct 4, 2011 (0d) |
| Oct 4, 2011 | ACAS | ↓ Sell | 364,619 | $6.29 | $2.3M | See | Oct 4, 2011 (0d) |
| Jul 21, 2011 | ACAS | ↓ Sell | 1,638,765 | $10.10 | $16.5M | Direct | Jul 26, 2011 (5d) |
| Jul 21, 2011 | ACAS | ↓ Sell | 270,934 | $10.06 | $2.7M | See | Jul 26, 2011 (5d) |
| Nov 22, 2010 | LNG | ↓ Sell | 2,000,000 | $6.38 | $12.8M | Direct | Nov 24, 2010 (2d) |
| Oct 27, 2008 | LNG | ↑ Buy | 124,085 | $1.46 | $182K | Direct | Oct 29, 2008 (2d) |
| Oct 23, 2008 | LNG | ↑ Buy | 24,478 | $1.15 | $28K | Direct | Oct 27, 2008 (4d) |
| Oct 23, 2008 | LNG | ↓ Sell | 24,478 | $1.15 | $28K | Direct | Oct 27, 2008 (4d) |
| Jun 15, 2007 | EMDA | ↑ Buy | 164,803 | $4.21 | $695K | Direct | Jun 18, 2007 (3d) |
| Mar 30, 2007 | CNUT | ↑ Buy | 203,100 | $5.05 | $1.0M | Direct | Apr 3, 2007 (4d) |
| Mar 29, 2007 | CNUT | ↑ Buy | 1,219,717 | $5.43 | $6.6M | Direct | Mar 30, 2007 (1d) |
| Mar 5, 2007 | CNUT | ↑ Buy | 1,764,762 | $5.66 | $10.0M | Direct | Mar 30, 2007 (25d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BHC insiders
Open-market trades in the last 12 months
About John Paulson's insider trades
John Paulson is a director at Bausch Health Companies (BHC). Since Mar 5, 2007, John has reported 15 open-market purchases worth $797.9M and 32 sales worth $801.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (74 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BHC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.